Tag: phase III
February 6, 2019
Eyenovia Announces FDA Acceptance of IND Application for MicroPine to Reduce the Progression of Myopia
Eyenovia (NASDAQ:EYEN) has announced that the US Food and Drug Administration has accepted its Investigational New Drug (IND) application to...
November 25, 2018
What is In-licensing?
In-licensing may be pharma’s preferred mode of business development these days. Should that impact your investment strategy?
September 28, 2018
Big News Roundup: Pacton Acquires “Golden Palms” Ground in Egina Area, Pilbara; Nevada Copper Hits with 19 Mineralized Holes: Enhances Potential of Open Pit Economics; First Cobalt Announces Inferred Mineral Resource for Iron Creek Project – Open at Depth and Along Strike
In case you missed it, here is this week's big news roundup.
May 8, 2018
Advantage Lithium Commences Preliminary Economic Assessment and Phase III Resource Conversion Program for the Cauchari Definitive Feasibility Study
Advantage Lithium Corp (TSXV:AAL; OTCQX:AVLIF) is pleased to announce that is has engaged WorleyParsons Chile S.A. (WP) to complete a... April 25, 2018
U.S. FDA Clears Pluristem’s Phase III Study in Treatment of Muscle Injury Following Hip Fracture Surgery
Pluristem Therapeutics (Nasdaq:PSTI) a leading developer of placenta-based cell therapy products, announced today that the U.S. Food and Drug Administration (FDA)... April 18, 2018
SilverCrest Delineates 10th High-Grade Vein at Las Chispas
SilverCrest Metals Inc. announced drill results from the Luigi vein on the Las Chispas property located in Sonora, Mexico. April 9, 2018